Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed)
The summary for the Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to support high risk, milestone-driven approaches for the development of robust culture techniques, and/or genetic and molecular tools to better understand the biology of select human eukaryotic pathogens including the microsporidian Enterocytozoon bieneusi; Pneumocystis jirovecii; Plasmodium vivax; and Babesia microti. This NOFO will use a milestone-driven, biphasic award mechanism. Transition to the second phase will depend on the successful completion of milestones.
| Federal Grant Title: | Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AI-23-055 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.855 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | February 2nd, 2024 |
| Original Application Deadline: | February 2nd, 2024 |
| Posted Date: | August 30th, 2023 |
| Creation Date: | August 30th, 2023 |
| Archive Date: | March 9th, 2024 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $250,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | August 30th, 2023 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-055.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
- • Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Anti...
- • Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...
- • Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
- • NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
- • NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)